Submitted by web@researchtop... on Mon, 08/02/2010 - 11:40
Use of Bevacizumab in the Neoadjuvant Setting for Patients with Locally Advanced Rectal Cancer
| CME test | Downloadable PDF | PowerPoint slides | CME Information and Faculty Disclosures |
| Read Dr Love's original email (from August 3, 2010) | Subscribe to Dr Love's email alerts | ||
Slides from a presentation at ASCO 2010 and transcribed comments from recent interviews with Axel Grothey, MD (7/9/10) and Alan P Venook, MD (6/16/10)
Schrag D et al. Neoadjuvant FOLFOX with bevacizumab but without pelvic radiation for locally advanced rectal cancer. Proc ASCO 2010;Abstract 3511.